Managing diabetes and COVID-19: A national strategic framework

被引：1

作者：

Mohan, Viswanathan ^{[1
,2
]}

Ramesh, Jagannathan ^{[3
]}

机构：

[1] Dr Mohans Diabet Special Ctr, 4 Conran Smith Rd, Chennai 600086, Tamil Nadu, India

[2] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India

[3] Indian Soc Clin Res, Bengaluru, Karnataka, India

来源：

INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES | 2020年 / 5卷 / 02期

关键词：

COVID-19; diabetes; higher risk; infection; precautions; PREVALENCE; POPULATION; INDIA;

D O I：

10.4103/jncd.jncd_39_20

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The coronavirus disease (COVID-19) pandemic has been one of the greatest health challenges that humanity has witnessed in recent times. Diabetes mellitus is one of the most common noncommunicable diseases and its prevalence is very high in evlderly people. COVID-19 also has a worse prognosis in elderly people. Hence, most of the data, both nationally and internationally, have shown that people with uncontrolled diabetes have worse outcomes compared to people without diabetes. This article reviews the connection between diabetes and COVID-19 and suggests various precautions to be taken for people with diabetes, the management strategies for diabetes and lays down a strategic framework for managing people with diabetes and COVID-19.

引用

页码：58 / 62

页数：5

共 13 条

[1] Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020 [J].

不详 .

DIABETES CARE, 2020, 43 :S98-S110

[2]

American Diabetes Association, 2021, DIABETES CARE, V45, pS1, DOI [DOI 10.2337/dc19-SINT01, 10.2337/dc22-Sint]

[3] Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study [J].

Anjana, Ranjit Mohan ;

Deepa, Mohan ;

Pradeepa, Rajendra ;

Mahanta, Jagadish ;

Narain, Kanwar ;

Das, Hiranya Kumar ;

Adhikari, Prabha ;

Rao, Paturi Vishnupriya ;

Saboo, Banshi ;

Kumar, Ajay ;

Bhansali, Anil ;

John, Mary ;

Luaia, Rosang ;

Reang, Taranga ;

Ningombam, Somorjit ;

Jampa, Lobsang ;

Budnah, Richard O. ;

Elangovan, Nirmal ;

Subashini, Radhakrishnan ;

Venkatesan, Ulagamathesan ;

Unnikrishnan, Ranjit ;

Das, Ashok Kumar ;

Madhu, Sri Venkata ;

Ali, Mohammed K. ;

Pandey, Arvind ;

Dhaliwal, Rupinder Singh ;

Kaur, Tanvir ;

Swaminathan, Soumya ;

Mohan, Viswanathan .

LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08) :585-596

[4] Type 2 Diabetes and its Impact on the Immune System [J].

Berbudi, Afiat ;

Rahmadika, Nofri ;

Tjahjadi, Adi Imam ;

Ruslami, Rovina .

CURRENT DIABETES REVIEWS, 2020, 16 (05) :442-449

[5] Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study [J].

Carey, Iain M. ;

Critchley, Julia A. ;

DeWilde, Stephen ;

Harris, Tess ;

Hosking, Fay J. ;

Cook, Derek G. .

DIABETES CARE, 2018, 41 (03) :513-521

[6] Clinical considerations for patients with diabetes in times of COVID-19 epidemic [J].

Gupta, Ritesh ;

Ghosh, Amerta ;

Singh, Awadhesh Kumar ;

Misra, Anoop .

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (03) :211-212

[7]

IDF, 2019, IDF Diabetes Atlas, Vninth

[8] Increase in the Incidence of Diabetes and Its Implications [J].

Ingelfinger, Julie R. ;

Jarcho, John A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (15) :1473-1474

[9] Diabetes in the Elderly [J].

Kalra, Sanjay ;

Sharma, Suresh K. .

DIABETES THERAPY, 2018, 9 (02) :493-500

[10] Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research [J].

Leon, Benjamin M. ;

Maddox, Thomas M. .

WORLD JOURNAL OF DIABETES, 2015, 6 (13) :1246-1258

← 1 2 →